OPRX logo

OptimizeRx Corporation Stock Price

NasdaqCM:OPRX Community·US$335.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

OPRX Share Price Performance

US$18.73
12.15 (184.65%)
30.6% undervalued intrinsic discount
US$27.00
Fair Value
US$18.73
12.15 (184.65%)
30.6% undervalued intrinsic discount
US$27.00
Fair Value
Price US$18.73
AnalystHighTarget US$27.00
AnalystConsensusTarget US$19.00
AnalystLowTarget US$11.00

OPRX Community Narratives

AnalystHighTarget·
Fair Value US$27 30.6% undervalued intrinsic discount

Digital Health Adoption And AI Will Drive Secular Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$19 1.4% undervalued intrinsic discount

Pharmaceutical Digital Engagement Will Unlock Future Value

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value US$11 70.3% overvalued intrinsic discount

Heightened Data Privacy And Provider Skepticism Will Hinder Healthcare Transformation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent OPRX News & Updates

Is OptimizeRx (NASDAQ:OPRX) Using Too Much Debt?

Oct 07
Is OptimizeRx (NASDAQ:OPRX) Using Too Much Debt?

Are Investors Undervaluing OptimizeRx Corporation (NASDAQ:OPRX) By 39%?

Aug 27
Are Investors Undervaluing OptimizeRx Corporation (NASDAQ:OPRX) By 39%?

OptimizeRx Corporation Key Details

US$104.7m

Revenue

US$37.3m

Cost of Revenue

US$67.5m

Gross Profit

US$77.3m

Other Expenses

-US$9.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.53
Gross Margin
64.39%
Net Profit Margin
-9.42%
Debt/Equity Ratio
23.8%

OptimizeRx Corporation Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

2 Risks
2 Rewards

About OPRX

Founded
2006
Employees
129
CEO
Stephen Silvestro
WebsiteView website
www.optimizerx.com

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 5.1%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.7%, driven by a loss of 2.5% in the Information Technology sector. In contrast to the last week, the market is actually up 13% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›